News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Michael Hofman: Oliver Sartor presenting PSMAfore at SNMMI
Photo from Michael Hofman/X
Jun 11, 2024, 06:42

Michael Hofman: Oliver Sartor presenting PSMAfore at SNMMI

Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre, shared a post on X/Twitter:

”Oliver Sartor presenting PSMAfore at SNMMI.

All efficacy endpoints favour Lu-PSMA617: better efficacy, quality of life, less side effects. Except, no difference in overall survival.”

Michael Hofman

Source: Michael Hofman/X

cancer Melbourne’s Peter MacCallum Cancer Centre Michael Hofman Oliver Sartor OncoDaily Oncology SNMMI
Special Coverage
Blog Posts
Sep 9, 2025, 17:52
Celebrating All the Extraordinary Pediatric Oncology Nurses Around the World - Childhood Cancer International
Insight
Sep 9, 2025, 17:43
Jeremy Slone: 1995 Study on Pediatric Kaposi Sarcoma in Zambia
Voices
Sep 9, 2025, 17:28
Miguel Bronchud: Lancet Oncology Abstract on Calls to Reform Cancer MDTs in the English NHS
Insight
Sep 9, 2025, 17:15
EORTC Highlights New Research on Immunogenic Effects of Radiotherapy in Cancer Care
Blog Posts
Sep 9, 2025, 17:03
Brian Walusimbi: Grateful for Aladina Foundation's Love and Support in Uganda
Insight
Sep 9, 2025, 16:53
NIH Launches a New Initiative to Create a 21st Century Biosafety Framework
Blog Posts
Sep 9, 2025, 16:51
Thanking Stephen V Liu and the IASLC Staff at WCLC25
Insight
Sep 9, 2025, 16:45
Mulugeta Ayalew Yimer: Urgent Need for Practical Strategies to Reduce Treatment Abandonment for Children with Cancer
Insight
Sep 9, 2025, 15:59
Big News for MSS Colorectal Cancer - Fight Colorectal Cancer
Voices
Sep 9, 2025, 15:50
Teresa Amaral: From Science to Access - Where are We in Cancer Care in 2025?
Voices
Sep 9, 2025, 15:49
Amol Akhade: EA5181 Trial Results in Unresectable Stage III NSCLC
Voices
Sep 9, 2025, 15:46
Mara Antonoff: Grateful for Women Thoracic Surgeons' Collaboration